Irreversible Electroporation of Locally Advanced Pancreatic Head Adenocarcinoma

Journal of Gastrointestinal Surgery

Volumn 17, Issue 10, 2013, Pages 1850-1856

  Martin, Robert C G ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Irreversible electroporation; Locally advanced pancreatic adenocarcinoma; Palliation

Indexed keywords

ADENOCARCINOMA; AGED; ARTICLE; CANCER STAGING; ELECTROPORATION; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PANCREAS TUMOR; PATHOLOGY; VERY ELDERLY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ELECTROPORATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS;

EID: 84884674717     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-013-2309-z     Document Type: Article

References (14)

1. Arnoletti JP, Frolov A, Eloubeidi M, Keene K, Posey J, Wood T, et al. A phase I study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advanced pancreatic cancer. Cancer Chemother Pharmacol. 2011;67: 891-7.
2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA: A Cancer Journal for Clinicians. 2013;63: 11-30.
3. Bilimoria KY, Bentrem DJ, Merkow RP, Tomlinson JS, Stewart AK, Ko CY, et al. Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors. J Am Coll Surg. 2007;205: 558-63.
4. Artinyan A, Soriano PA, Prendergast C, Low T, Ellenhorn JD, Kim J. The anatomic location of pancreatic cancer is a prognostic factor for survival. HPB (Oxford). 2008;10: 371-6.
5. Al-Sakere B, Andre F, Bernat C, Connault E, Opolon P, Davalos RV, et al. Tumor ablation with irreversible electroporation. PloS one. 2007;2: e1135.
6. Edd JF, Horowitz L, Davalos RV, Mir LM, Rubinsky B. In vivo results of a new focal tissue ablation technique: irreversible electroporation. IEEE Trans Biomed Eng. 2006;53: 1409-15.
7. Davalos RV, Mir IL, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng. 2005;33: 223-31.
8. Davalos RV, Otten DM, Mir LM, Rubinsky B. Electrical impedance tomography for imaging tissue electroporation. IEEE Trans Biomed Eng. 2004;51: 761-7.
9. Martin RC, 2nd, McFarland K, Ellis S, Velanovich V. Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma. J Am Coll Surg. 2012;215: 361-9.
10. Martin RC, 2nd, McFarland K, Ellis S, Velanovich V. Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival. Annals of Surgical Oncology. 2012;doi: 10. 1245/s10434-012-2736-1.
11. Callery MP, Chang KJ, Fishman EK, Talamonti MS, William Traverso L, Linehan DC. Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol. 2009;16: 1727-33.
12. Varadhachary GR, Tamm EP, Abbruzzese JL, Xiong HQ, Crane CH, Wang H, et al. Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol. 2006;13: 1035-46.
13. Bower M, Sherwood L, Li Y, Martin R. Irreversible electroporation of the pancreas: definitive local therapy without systemic effects. J Surg Oncol. 2011;104: 22-8.
14. Charpentier KP, Wolf F, Noble L, Winn B, Resnick M, Dupuy DE. Irreversible electroporation of the pancreas in swine: a pilot study. HPB: the official journal of the International Hepato Pancreato Biliary Association. 2010;12: 348-51.